![RebrAIn raises 3.7 million euros to support the fight against Parkinson's disease RebrAIn raises 3.7 million euros to support the fight against Parkinson's disease](medias/org-1549/shared/altai--r-deal--rebrain-66101bd5ad16f.png)
RebrAIn raises 3.7 million euros to support the fight against Parkinson's disease
Published on :
05/04/2024
05
April
Apr
04
2024
Altaïr Avocats advised RebrAIn, a Bordeaux-based medtech company, in their €3.7 million fundraising. Founded in 2021, RebrAIn has developed a solution aimed at simplifying electrode placement in the brain for patients suffering from Parkinson's disease or tremors.
The Bordeaux-based medtech RebrAIn, incubated at Chrysa-link and led by David Caumartin, Emmanuel Cuny, and Nejib Zemzemi, has developed an innovative technology based on artificial intelligence to improve Deep Brain Stimulation (DBS), a surgical intervention used notably to treat Parkinson's disease.
Through a precise targeting method and a collaborative health data registry, this technology aims to simplify, standardize, and make DBS more accessible, which, until now, has only been used by 3% of eligible patients worldwide.
RebrAIn has completed a €3.7 million Seed funding round, led by Karista and supported by Nouvelle Aquitaine CO-Investment (NACO), a significant milestone for RebrAIn.
RebrAIn aims to accelerate its commercial development internationally, particularly in the United States, and to intensify its R&D efforts. The funds will also be used to expand RebrAIn's team, with the recruitment of data scientists and sales personnel.
The parties involved in this transaction:
Altaïr Avocats supported RebrAIn on its corporate aspects with Sébastien Péronne, partner Marie Elgart, and Aude Idris, associates, complemented by the support of the IP/IT team composed of Christophe Héry, partner, and Albane Watine, associate.
History
-
Dassault Systèmes acquires Amcad Engineering
Published on : 18/09/2024 18 September Sep 09 2024Deals ENAltaïr Avocats assisted Amcad Engineering, a software developer specializing...
-
QL Clean France acquires Etanchéité du Sud Ouest
Published on : 23/07/2024 23 July Jul 07 2024Deals ENAltaïr Avocats supported the consortium QL Clean France in the acquisition of...
-
Orus Energy raises €2.2 million (seed)
Published on : 12/07/2024 12 July Jul 07 2024Deals ENAltaïr Avocats advised Orus Energy, an energy flexibility platform, during it...
-
ARKEA CAPITAL (WE POSITIVE INVEST 2) and VOLNEY DÉVELOPPEMENT participate in €9 million fund-raising for QUALIRETRAITE
Published on : 04/06/2024 04 June Jun 06 2024Deals ENAltaïr Avocats advised ARKEA CAPITAL (WE POSITIVE INVEST 2) and VOLNEY DÉVELO...
-
Astem Digital acquires Deep Company
Published on : 10/04/2024 10 April Apr 04 2024Deals ENAltaïr Avocats has advised entrepreneur Cédric Baümer and the Astem Digital g...
-
RebrAIn raises 3.7 million euros to support the fight against Parkinson's disease
Published on : 05/04/2024 05 April Apr 04 2024Deals ENAltaïr Avocats advised RebrAIn, a Bordeaux-based medtech company, in their €3...
-
Transports Veynat strengthens its territorial deployment with the strategic acquisition of Transports Klein, a gateway to the international market
Published on : 29/02/2024 29 February Feb 02 2024Deals ENAltaïr Avocats has advised Transports Veynat, the French leader in the transp...
-
WE POSITIVE INVEST 2 (ARKEA CAPITAL), WILLE FINANCE and SWEN CAPITAL complete the €8 million fundraising of Beedeez
Published on : 06/02/2024 06 February Feb 02 2024Deals ENAltaïr Avocats has advised a consortium of investors, WE POSITIVE INVEST 2 (A...
-
HEPHAISTOS-Pharma raises €2 million (seed) to accelerate the development of their ONCO-Boost treatment
Published on : 31/01/2024 31 January Jan 01 2024Deals ENAltaïr Avocats has advised HEPHAISTOS-Pharma, a key player in the biotechnolo...